STOCK TITAN

Pzena Investment tops 10 % ownership in Varex Imaging filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Pzena Investment Management LLC has filed Amendment No. 1 to Schedule 13G disclosing a passive ownership position in Varex Imaging Corporation (VREX).

  • The value-oriented investment adviser now beneficially owns 4,244,977 common shares, representing 10.2 % of VREX’s outstanding stock.
  • Sole voting power: 3,108,798 shares; sole dispositive power: the full 4,244,977 shares. No shares are held with shared voting or dispositive authority.
  • The filing is made under Rule 13d-1(b) as an institutional investment adviser (IA), indicating the stake is held in the ordinary course of business and not for the purpose of influencing control.
  • All shares are held on behalf of clients; no single client owns more than 5 % of the class.
  • The filing date of the event is 30 June 2025; signature is dated 3 July 2025 by Chief Legal Risk & Compliance Officer Steven Coffey.

The >10 % threshold places Pzena among the largest institutional holders of VREX, potentially increasing trading liquidity and indicating external confidence in the company’s valuation, although the passive 13G designation suggests no activist intent.

Positive

  • Pzena Investment Management’s 10.2 % ownership introduces a respected institutional value investor to VREX’s top holder list, potentially strengthening market confidence.

Negative

  • None.

Insights

TL;DR: Pzena’s passive 10.2 % stake signals institutional confidence; moderately positive for sentiment.

Pzena, a well-regarded deep-value manager, has accumulated 4.24 M VREX shares. Crossing the 10 % threshold is material because it elevates the firm to a significant shareholder class and must be disclosed. While the filing is passive (13G), the market often interprets a double-digit position by a specialist value investor as a validation of intrinsic value, which can tighten the valuation discount. The absence of shared voting/dispositive power shows centralized control within Pzena, simplifying any future block liquidity events. From a liquidity perspective, VREX now has a long-term holder that may dampen free-float turnover but can also provide price support. Overall, the disclosure is modestly bullish and could improve investor perception.

TL;DR: Passive filing limits governance impact; disclosure mainly increases transparency.

Because the Schedule 13G is filed under Rule 13d-1(b), Pzena affirms no intention to influence control, propose directors, or engage in activism. Therefore, immediate governance ramifications are minimal. However, a 10 % holder has the right to engage more actively in the future, and its presence may subtly encourage management accountability. The concentration of ownership also means any future switch from 13G to 13D would be closely watched. At present, impact is mostly informational.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



PZENA INVESTMENT MANAGEMENT LLC
Signature:s/Steven Coffey
Name/Title:Chief Legal Risk Officer & Chief Compliance Officer
Date:07/03/2025

FAQ

How many VREX shares does Pzena Investment Management now own?

Pzena reports 4,244,977 common shares, equal to 10.2 % of VREX’s outstanding stock.

Does Pzena have activist intentions toward Varex Imaging?

The filing is on Schedule 13G, indicating a passive investment with no intent to influence control.

What voting power does Pzena hold?

Pzena has sole voting power over 3,108,798 shares and no shared voting power.

When was the 10.2 % stake effective?

The event triggering the filing occurred on 30 June 2025; the certification was signed on 3 July 2025.

Why is a 10 % threshold significant for investors?

Crossing 10 % makes the holder a major beneficial owner, often affecting liquidity, sentiment and future governance monitoring.
Varex Imaging Corp

NASDAQ:VREX

View VREX Stock Overview

VREX Rankings

VREX Latest News

VREX Latest SEC Filings

VREX Stock Data

470.76M
41.23M
Medical Devices
Electronic Components, Nec
Link
United States
SALT LAKE CITY